59 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.
Universities Of Lille
2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agents.
University Of Groningen
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.
University Of Minnesota
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
Universit£
Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.
Universit£
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.
Iqm-Csic
Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential.
Iqm-Csic
Efficient synthesis of hexahydroindenopyridines and their potential as melatoninergic ligands.
Universidad De Valencia
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
The German University In Cairo
Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT(2)-selective melatonin agonists: improving metabolic stability.
Hong Kong University Of Science And Technology
Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors.
Paris-Sud University
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.
Universit£
Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
Universit£
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
University Of Lille
Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
King'S College London
Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.
Universit£
Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.
Takeda Pharmaceutical
Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
University Of Lille
1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT2-selective agonists.
Takeda Pharmaceutical
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
University Of Lille
Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.
Universit£
Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
Merck Research Laboratories
Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.
Hong Kong University Of Science And Technology
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
University Of W£Rzburg
Synthesis and receptor binding studies of quinolinic derivatives as melatonin receptor ligands
TBA
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
University Of WüRzburg
Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
University Of Lille 2
Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
University Of WüRzburg
Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
Université
Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
University Of Athens
(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.
Bristol-Myers Squibb Pharmaceutical Research Institute
Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists.
Bristol-Myers Squibb Pharmaceutical Research Institute
N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist.
Bristol-Myers Squibb Pharmaceutical Research Institute
Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
Bristol-Myers Squibb Pharmaceutical Research Institute
4-Substituted anilides as selective melatonin MT2 receptor agonists.
Bristol-Myers Squibb Pharmaceutical Research Institute
Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.
Bristol-Myers Squibb Pharmaceutical Research Institute
Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.
Bristol-Myers Squibb Pharmaceutical Research Institute
Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
Université
Indanyl piperazines as melatonergic MT2 selective agents.
Bristol-Myers Squibb Pharmaceutical Research Institute
Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.
Takeda Chemical Industries
Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists.
Takeda Chemical Industries
Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
Institut De Chimie Pharmaceutique Albert Lespagnol
Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).
Institut De Chimie Pharmaceutique Albert Lespagnol
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.
Paris-Sud University
Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors.
Duquesne University
Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore.
Beni-Suef University